Matchmaker Seeks Drug Company: Must Have Pipeline, $85 Billion

(Bloomberg) -- As investor discontent simmers over Bristol-Myers Squibb Co.’s $74 billion takeover of Celgene Corp., the possibility of a surprise buyer swooping in with an offer for Bristol-Myers ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.